Thermo Fisher Scientific Inc. (TMO) recently began the process of issuing public notice to the holders of Floating Rate Convertible Senior Debentures of Apogent Technologies Inc. that are due in 2033, reminding them of their rights to convert the debentures. Thermo Fisher accepted this debt as part of its acquisition of Fisher Scientific International Inc. in 2006 which in turn acquired Apogent Technologies in 2004.

As per the indenture/agreement, these debentures have now become convertible as Thermo Fisher’s stock traded above the minimum specified price over the applicable measurement period. The debentures can be converted by the end of this year. Thermo Fisher will use its cash or a combination of cash and its common stock to settle the conversion.

Thermo Fisher is a scientific instrument maker and a world leader in serving science. The company was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. in November, 2006. Thermo Fisher Scientific serves its customers through two principal brands: Thermo Scientific and Fisher Scientific.

Thermo Scientific is the company’s technology brand that offers a complete range of high-end analytical, laboratory instruments, software, services, consumables and reagents to enable integrated laboratory workflow solutions. The Fisher Scientific brand offers a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education markets.

Thermo Fisher Scientific operates through two business segments – Analytical Technologies and Laboratory Products and Services. The company generated revenues of $10,498 million in fiscal 2008, an increase of approximately 8% year over year. Thermo Fisher’s main competitors are Agilent Technologies Inc. (A), Beckman Coulter Inc. (BEC) and Danaher Corp. (DHR).

Zacks Investment Research
View original at: Zacks.com News Feed

1. (BSX) Boston Scientific Readies for Clinical TrialBoston Scientific Corporation (BSX) announced its first patient enrollment for the MADIT-RIT clinical trial. The...
2. (MET) MetLife Issues Fixed Rate NotesOn Sep 10, 2009, Metropolitan Life Global Funding I, a unit of MetLife Inc (MET)...
3. (TMO) Thermo Fisher Scientific Inc Buys BRAHMSThermo Fisher Scientific Inc. (TMO) recently agreed to acquire B.R.A.H.M.S. AG for 330 million Euros...
4. (USB) US Bancorp Issues Senior NotesOn Sept. 2, 2009, US Bancorp (USB) announced the sale of 3.5 year senior notes...
5. (BSX) Boston Scientific Registers Positive Results From MADIT TrialBSX: Positive Results from MADIT Trial Boston Scientific Corporation (BSX) announced positive final results from...
6. (BSX) Boston Scientific is Ready For MADIT ResultsBoston Scientific Corp. (BSX) is geared up for its landmark MADIT-CRT trial final results, which...

Search Posts by Tag: A | Agilent Technologies Inc | BEC | Beckman Coulter Inc | Danaher Corporation | DHR | Thermo Fisher Scientific Inc | TMO | Scientific & Technical Instruments | Technology

RSS Feeds by Tag: A | Agilent Technologies Inc | BEC | Beckman Coulter Inc | Danaher Corporation | DHR | Thermo Fisher Scientific Inc | TMO | Scientific & Technical Instruments | Technology |

Other Posts by: vitalstocks | RSS Feed for this author